Healthcare Professionals Communications

Last Updated on February 18, 2022

DRAP’s issues safety updates and alerts related to the therapeutic goods in order to ensure that healthcare professionals and other stakeholders have timely access to the relevant information on safety, quality and efficacy issues or benefit/risk evaluations of the drugs, vaccines and medical devices. Such information updates are issues time to time from the DRAP, and mainly includes the new scientific and regulatory information updates in line with the principles of reliance on the information generated by the reference regulatory authorities on the safety and efficacy of therapeutic goods.

Therapeutic products requires continuous monitoring to evaluate the benefits-risk ratio throughout the lifecycle, to mitigate and minimize any known or suspected risks associated with them. This section includes information updates primarily for healthcare professionals (physicians, pharmacists, nurses, etc) and other stakeholders to provides an insight on the benefit / risk assessment of the products including the information on how to identify and mitigate the risks, and possible actions which can be taken by the healthcare professionals. These communications are aimed at assisting healthcare professionals and consumers to make informed decisions about their use of therapeutic goods..

The following section provides the list of product safety updates issued.

Issued OnAlert Titles 
September 10, 2021Risk of Serious Heart Related Events, Cancer, Blood Clots, and Death With Tofacitinib
View
June 04, 2020Safety Alert of Falsified and Contaminated Defibrotide Identified in WHO RegionsView
May 06, 2020Safety Alert of Detection of NDMA in Ranitidine Containing MedicinesView
April 15, 2020Safety Alert of Falsified Chloroquine Products Circulating in the WHO Region of AfricaView
April 14, 2020Safety Alert of Falsified Medical Products, including In Vitro Diagnostics, that claim to Prevent, Detect, Treat or Cure COVID-19View
April 06, 2020Safety Alerts - Serious Mental Health Side Effects with Asthma and Allergic Drugs MontelukastView
March 13, 2020Safety Alerts of Falsified Anti-malarial in West and Central Africa Displaying an Outdated WHO Essential Drugs Programme LogoView
February 11, 2020 Safety Alert - Quality Defect in LPV Vaccine Imported from IndiaView
November 06, 2019Alert of Falsified Amoxicillin + Clavulanic Acid Products Circulating In HaitiView
October 18, 2019Alert of Falsified Quinine Bisulphate: Circulating In Uganda And Quinine Sulphate Circulating In Central African Republic And ChadView
October 17, 2019Safety Alert Of Risk Of Serious Cardiac Adverse Events Associated With Domperidone In Children Under 12 Years Of AgeView
October 02, 2019Detection Of NDMA In Ranitidine MedicinesView